CUE-101
202106015
Phase 2 small_molecule active
Quick answer
CUE-101 for Oropharyngeal Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Cue Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cue Biopharma
- Indication
- Oropharyngeal Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active